Flow Cytometry of Hematological Malignacies

ISBN-13: 9781119611257 / Angielski / Twarda / 2021 / 464 str.

Claudio Ortolani

Spis treści

Foreword to the First Edition by Maryalice Stetler-StevensonForeword to the First Edition by Bruno BrandoForeword to the Second Edition by Michael J BorowitzPreface to the First EditionPreface to the Second Edition1 ANTIGENSClustered (CD) AntigensCD1 Antigens, XXCD2 Antigen, XXCD3 Antigen, XXCD4 Antigen, XXCD5 Antigen, XXCD7 Antigen, XXCD8 Antigen, XXCD10 Antigen, XXCD11b Antigen, XXCD11c Antigen, XXCD13 Antigen, XXCD14 Antigen, XXCD15 Antigen, XXCD16 Antigen, XXCD19 Antigen, XXCD20 Antigen, XXCD22 Antigen, XXCD23 Antigen, XXCD24 Antigen, XXCD25 Antigen, XXCD26 Antigen, XXCD27 Antigen, XXCD28 Antigen, XXCD30 Antigen, XXCD33 Antigen, XXCD34 Antigen, XXCD38 Antigen, XXCD43 Antigen, XXCD45 Antigen, XXCD45 Isoforms, XXCD48 Antigen, see SLAM molecules, XXCD49 Antigens, XXCD56 Antigen, XXCD57 Antigen, XXCD61 Antigen, XXCD62L Antigen, XXCD64 Antigen, XXCD65 Antigen, XXCD66c Antigen, XXCD71 Antigen, XXCD79 Antigen, XXCD81 Antigen, XXCD84 Antigen, see SLAM molecules, XXCD103 Antigen, XXCD123 Antigen, XXCD117 Antigen, XXCD138 Antigen, XXCD150 Antigen, see SLAM molecules, XXCD158 Antigen, see KIRs, XXCD181-186, 191-199 Antigens, see Chemokines and Chemokine Receptors, XXCD200 Antigen, XXCD229 Antigen, see SLAM molecules, XXCD244 Antigen, see SLAM molecules, XXCD280-290 Antigens, see Toll-like Receptors, XXCD305 Antigen, XXCD307 (IRTA) Antigen Family, XXCD319 Antigen, see SLAM molecules, XXCD352-353 Antigens, see SLAM molecules, XXCD371 Antigen, XXNon clustered (or primarily known with other names) antigensBcl-2 Protein, XXChemokines and Chemokine Receptors, XXCRLF2, XXCytotoxic Proteins, XXHLA-DR Antigen, XXImmunoglobulins, XXKIR, CD158 Isoforms, XXMyeloperoxidase (MPO), XXNG2 Antigen, XXPCA-1 Antigen, XXROR-1 Antigen, XXSLAM Molecules and SLAM Associated Protein (SAP), XXSOX11, XXT-cell Receptor (TCR), XXTerminal Deoxy-nucleotidyl Transferase (TdT), XXToll-like Receptors (TLR), XXVS38 Antigen, XXZAP-70 Protein, XX2 DISEASESMyeloproliferative neoplasms, XXXChronic myeloid leukemia (CML), XXXMyeloproliferative neoplasms other than CML, XXXChronic neutrophilic leukemia (CNL), XXXPolycythemia vera (PV), XXXPrimary myelofibrosis (PMF), XXXEssential thrombocythemia (ET), XXXChronic eosinophilic leukemia (CEL), XXXMastocytosis, XXXAcute masT-cell leukemia (AMCL), XXXChronic masT-cell leukemia (CMCL), XXXMyelomastocytic leukemia (MML), XXXMyelodysplastic/myeloproliferative neoplasms, XXXChronic myelomonocytic leukemia (CMML), XXXOther myelodysplastic/myeloproliferative neoplasms and related conditions, XXXJuvenile myelomonocytic leukemia (JMML), XXXAtypical CML bcr/abl negative (ACML), XXXRAS-associated autoimmune leukoproliferative disorder (RALD), XXXMyelodysplastic syndromes, XXXMyeloid neoplasms with germline predisposition, XXXAcute myeloid leukemias, XXXAMLs with recurrent genetic anomalies, XXXAMLs with chromosomal anomalies, XXXAMLs with gene mutations, XXXAMLs with recurrent genetic anomalies, not recognized by the WHOclassification, XXXAMLs with myelodysplastic related changes (AML-MRC), XXXAMLs not otherwise specified, XXXAML with minimal differentiation, XXXAML without maturation, XXXAML with maturation, XXXAcute myelomonocytic leukemia (AMMoL), XXXAcute monoblastic or monocytic leukemia (AMoL), XXXPure erythroid leukemia (PEL), XXXAcute megakaryoblastic leukemia (AMKL), XXXAcute basophilic leukemia (ABL), XXXMyeloid proliferations associated with Down syndrome, XXXTransient abnormal myelopoiesis (TAM), XXXAMLs in patients with Down syndrome, XXXBlastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL), XXXAcute leukemias with ambiguous lineage attribution (ALAL), XXXAcute undifferentiated leukemias (AUL), XXXMixed phenotype acute leukemias (MPAL), XXXNeoplastic diseases of B and T lymphatic precursors, XXXB lymphoblastic leukemia/lymphoma,not otherwise specified (B-ALL/LBLnos), XXXB lymphoblastic leukemia/lymphoma with recurrent genetic anomalies, XXXT lymphoblastic leukemia/lymphoma (T-ALL/LBL), XXXEarly T-cell precursors lymphoblastic leukemia (ETP-ALL), XXXNK lymphoblastic leukemia/lymphoma (NK-ALL/LBL), XXXNeoplastic diseases of mature B cells, XXXChronic lymphocytic leukemia/smalllymphocytic lymphoma (B-CLL/SLL), XXXFamilial B-CLL, XXXRichter syndrome, XXXMonoclonal B-cell lymphocytosis (MBL), XXXB-cell prolymphocytic leukemia (B-PLL), XXXLymphoplasmacytic lymphoma (LPL), XXXHeavy chain disease (HCD), XXXGamma heavy chain disease, XXXMu heavy chain disease, XXXAlpha heavy chain disease, XXXHairy cell leukemia (HCL), XXXHairy cell leukemia, variant (HCL-v), XXXHairy cell leukemia, Japanese variant (HCL-J), XXXSplenic diffuse red pulp lymphoma (SDRPL), XXXMarginal zone lymphomas (MZL), XXXNodal marginal zone lymphoma (NMZL), XXXSplenic marginal zone lymphoma (SMZL), XXXExtranodal marginal zone lymphoma (EMZL/MALToma), XXXClonal B-cell lymphocytosis with MZL-like phenotype (CBL-MZ), XXXFollicular lymphoma (FCL), XXXTesticular follicular lymphoma, XXXDuodenal type follicular lymphoma, XXXPediatric type follicular lymphoma, XXXPrimitive cutaneous follicular lymphoma (PCFL), XXXLarge B-cell lymphoma with IRF4 rearrangement, XXXMantle cell lymphoma (MCL), XXXBlastic mantle cell lymphoma (BMCL), XXXLeukemic non nodal mantle cell lymphoma, XXXDiffuse large B-cell lymphomas (DLBCLs), XXXDLBCL not otherwise specified (DLBCL nos), XXXT-cell/histiocyte-rich B-cell lymphoma (THRLBCL), XXXPrimary DLBCL of the CNS (PCNSL), XXXPrimary cutaneous DLBCL, "leg type", XXXEBV(+) DLBCL nos, XXXDLBCL associated with chronic inflammation (PAL), XXXLymphomatoid granulomatosis (LyG), XXXPrimary mediastinal B-cell lymphoma (PMBCL), XXXIntravascular large B-cell lymphoma (IVBCL), XXXALK-positive large cell lymphoma (ALK(+) LBCL), XXXPlasmablastic lymphoma (PBL), XXXPrimary effusion lymphoma (PEL), XXXHHV8-associated lymphoproliferative disorders, XXXBurkitt lymphoma (BL), XXXBurkitt leukemia with immature phenotype, XXXBurkitt-like lymphoma with 11q aberrations, XXXHigh grade B-cell lymphoma (HGBL), XXXPlasma cell neoplasms, XXXMonoclonal gammopathies of undetermined significance (MGUS), XXXMultiple myeloma (MM), XXXPlasma cell leukemia (PCL), XXXNeoplastic diseases of mature T and NK cells, XXXT-cell prolymphocytic leukemia (T-PLL), XXXT-cell large granular lymphocytic leukemia (T-LGL), XXXChronic lymphoproliferative disorders of NK cells (CLPD-NK/CNKL), XXXAggressive NK-cell leukemia (ANKL), XXXAdult T-cell leukemia/lymphoma (ATLL), XXXExtranodal NK/T-cell lymphoma, "nasal type" (ENKTL), XXXIntestinal T-cell lymphoma (ITCL), XXXEnteropathy-associated T-cell lymphoma (EATCL), XXXMonomorphic epitheliotropic intestinal T-cell lymphoma (MEITL), XXXIndolent gastro-intestinal T lymphoproliferative disorder, XXXHepatosplenic T-cell lymphoma (HTSCL), XXXSubcutaneous panniculitis-like T-cell lymphoma (SPTCL), XXXMycosis fungoides (MF), XXXSézary syndrome (SS), XXXPrimary cutaneous CD30(+) lymphoproliferative disorders, XXXLymphomatoid papulosis (LyP), XXXPrimary cutaneous anaplastic T-cell lymphoma (cALCL), XXXPrimary cutaneous peripheral T-cell lymphoma (PTCL), XXXPrimary cutaneous TCRgammadelta(+) T-cell lymphoma (PCGD-TCL), XXXPrimary cutaneous CD8(+) aggressive epidermotropiccytotoxic T-cell lymphoma, XXXPrimary cutaneous acral CD8(+) T-cell lymphomaPrimary cutaneous lymphoma of the medium/small CD4(+) T cells(PCSM-TCL), XXXPeripheral T-cell lymphoma, not otherwise specified (PTCLnos), XXXNodal lymphomas of follicular T-helper derivation, XXXAngioimmunoblastic T-cell lymphoma (AITL), XXXFollicular T-cell lymphoma (FTCL), XXXNodal PTCL with follicular T-helper phenotype, XXXAnaplastic large cell lymphoma ALK(+) (ALK(+) ALCL), XXXAnaplastic large cell lymphoma ALK(-) (ALK(-) ALCL), XXXBreast implant-associated anaplastic large cell lymphoma (biaALCL), XXXNeoplastic diseases of histiocytic and dendritic cells, XXXHistiocytic sarcoma (HS), XXXLangerhans cell histiocytosis (LCH), XXXIndeterminate dendritic cell tumor (IDCT), XXXInterdigitating dendritic cell sarcoma (IDCS), XXXFollicular dendritic cell sarcoma (FDCS), XXXErdheim-Chester disease (EDC), XXX3 APPENDIXAcute leukemias not recognized by the 2016 WHO classification, XXXAcute leukemia of myeloid/NK precursors (M/NK-AL), XXXAcute leukemia of myeloid dendritic cells (MDCL), XXXAcute leukemia of Langerhans cells, XXXMature B-cell lymphoblastic leukemia, XXXComposite lymphomas, XXXHypereosinophilic syndrome (HES), lymphocyte variant, XXXIndolent T lymphoblastic proliferations (iT-LBP), XXXPolyclonal lymphocytoses of B lymphocytes, XXXPersistent polyclonal B-cell lymphocytosis (PPBL), XXXPersistent polyclonal CD5(+) B-cell lymphocytosis, XXXPersistent polyclonal B-cell lymphocytosis, Japanese (hairy) variant, XXXPolyclonal plasmacytoses, XXXSmall round (blue) cell tumors (SR(B)CT), XXXIndex

O autorze

About the authorClaudio Ortolani is an expert in the area of diagnosis of hematological malignancies. Now retired, Dr Ortolani was Consultant in the Department of Clinical Pathology at Venice General Hospital, Venice, Italy. He is one of the founding members of the Italian Society for Cytometric Cell Analysis (ISCCA), of whose board he is currently a member. He has taught and lectured internationally on how to use flow cytometry to aid in diagnosing hematological diseases.